Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Former Roche oncology head joins AAA board

This article was originally published in Scrip

Executive Summary

Molecular nuclear medicines specialist, Advanced Accelerator Applications (AAA), has appointed Kapil Dhingra to its board of directors as an independent non-executive director. Prior to joining the AAA board, Dr Dhingra was head of oncology at Roche. He is currently head of KAPital Consulting, a healthcare consulting firm he founded in 2008, and is an advisor or member of several biotechnology and pharmaceutical companies' boards. Saint-Genis-Pouilly, France-based AAA's board is chaired by Claudio Costamagna and consists of nine directors.






Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts